Company Profile
[16.07.2015 - Curia Acquires Gadea Grupo Farmacéutico SL]
Gadea Pharmaceutical Group is a Spanish company dedicated to the development, manufacturing and marketing of APIs located in Valladolid. We provide value to our worldwide customers because our solid and timely chemical development & high quality products and services. We have a solid intellectual property base, which includes patents and proprietary knowledge. We are focused on the development and manufacturing according to cGMP guidelines, of specialty generics with complex multi - step chemistry. We can offer early access to high added value APIs. RAGACTIVES offers specialty generic APIs such as: Dorzolamide, Tamsulosine, Mizolastine, Tolterodine, Ropinirole, Pramipexole, Olopatadine, Atracurium Besylate and others. Contract Development & Customised Synthesis: Process design and synthesis route capabilities
